US pharma giant Pfizer will showcase data across its portfolio of potential breakthrough cancer medicines at the 2025 ...

Chicago-based pharma major AbbVie and privately-held San Diego biotech ADARx Pharmaceuticals have announced a collaboration ...

US President Donald Trump released an executive order on May 12 calling for a 30-day negotiation period between the ...

Fibrosis drug developer Tvardi Therapeutics has hit the ground running after completing its merger with troubled US biotech ...

UK-based Kaerus Bioscience, a biopharma created by European investment firm Medicxi for the development of therapeutics for ...

US biotech Cytokinetics has unveiled fresh Phase III data backing its heart drug aficamten, showing the treatment was more ...

In a further bid to expand its already lucrative portfolio of metabolic and obesity medicines, Denmark’s Novo Nordisk (NOV: N ...

San Diego, USA-based biotech Capricor Therapeutics (Nasdaq; CAPR) yesterday announced the appointment of Dr Michael Binks as ...

Finnish biotech Tilt Biotherapeutics has raised $26 million (22.6 million euros) in a series B round to move its lead cancer ...

Danish CNS specialist Lundbeck (LUND: CO) today released first-quarter 2025 financials, along with a raised guidance for the ...

Cambridge, USA-based biotech Stylus Medicine, which says it is dedicated to developing transformative in vivo genetic ...

Belgian biotech Galapagos (Euronext: GLPG) is pausing its high-profile plan to break into two separate businesses, just five ...